Saturday

Infectious, Paraneoplastic, CME: 2.75 hours

January 16, 2016
Autoimmune? Diagnosis 8:00 a.m.–11:00 a.m.
and Treatment of Rapidly
Progressive Encephalopathies

Program Director Allen J. Aksamit, Jr., MD, FAAN, Rochester, MN

Program Description
Faculty will highlight advances and emerging concepts in encephalitis, a rapidly expanding area of neurology. The
goal is to provide updates for rational expert opinion-based actionable approaches to diagnosis and treatment of
infectious, autoimmune, and paraneoplastic encephalitis.
Learning Objectives Recommended Audience
Participants should become familiar with the differential Trainee; General Neurologist; Specialist Neurologist;
diagnosis of infectious, autoimmune, and paraneoplastic Advanced Practice Provider
encephalitides; understand the rational use of antibody
testing and microbiologic/viral diagnostics for defining
Core Competencies
encephalitis; become familiar with expert opinion Medical Knowledge; Patient Care; Practice-based
strategies for using immunosuppression as treatment for Learning and Improvement
autoimmune and paraneoplastic encephalitis.

Schedule
8:00 a.m.–8:50 a.m. Diagnosis and Management of Acute Viral Encephalitis
Allen J. Aksamit, Jr., MD, FAAN, Rochester, MN

8:50 a.m.–8:55 a.m. Questions and Answers

Allen J. Aksamit, Jr., MD, FAAN, Rochester, MN

8:55 a.m.–9:45 a.m. Paraneoplastic Encephalitis and Autoimmune Encephalitis

Sean J. Pittock, MD, Rochester, MN

9:45 a.m.–9:50 a.m. Questions and Answers

Sean J. Pittock, MD, Rochester, MN

9:50 a.m.–10:05 a.m. Break

10:05 a.m.–10:55 a.m. Immunosuppression for Treatment of Autoimmune and Paraneoplastic Encephalopathies
Jeffrey Gelfand, MD, San Francisco, CA

10:55 a.m.–11:00 a.m. Questions and Answers

Jeffrey Gelfand, MD, San Francisco, CA

RECOMMENDED COMPANION COURSE  –  PAGE 18

Infectious, Paraneoplastic, and Autoimmune Encephalopathies: Advances in Clinical Diagnosis and Emerging Insights
About Pathogenesis

14  2016 Breakthroughs in Neurology

 Saturday
Infectious, Paraneoplastic, and CME: 2.75 hours
January 16, 2016
Autoimmune Encephalopathies: 1:15 p.m.–4:15 p.m.
Advances in Clinical Diagnosis and
Emerging Insights About Pathogenesis

Program Director Michael R. Wilson, MD, San Francisco, CA

Program Description
This session will highlight the increasingly important and common clinical and scientific problem of diagnosis and
treatment of neuroinflammatory syndromes—a topic of great interest to practicing neurologists and one of the
most exciting and innovative areas of scientific discovery in neurology. The session will discuss the most helpful
clinical features and phenotypes of CNS inflammatory syndromes for differential diagnosis, clinical interpretation of
commercially available tests, the ongoing refinement of antibody and pathogen testing, and the development of new
and exciting ways to detect pathogens using high-throughput approaches. The session will provide a summary for
the clinical neurologist to approach diagnostic testing for infectious and inflammatory causes in these patients.
Learning Objectives Recommended Audience
Upon completion, participants should be able to Trainee; General Neurologist; Specialist Neurologist;
review the latest research on the optimal treatment Advanced Practice Provider
and management of cryptococcal meningitis and
cryptococcal meningitis immune reconstitution
Core Competencies
inflammatory syndrome; discuss the use of Medical Knowledge; Patient Care;
metagenomic deep sequencing technologies for Systems-based Practice
identification of infectious causes of meningitis
and encephalitis; explore the latest data on the
differential diagnosis and management of
autoimmune encephalopathies

Schedule
1:15 p.m.–2:00 p.m. Approach to Characterizing Neuroinflammatory Disorders in Children
Ariane Soldatos, MD, Bethesda, MD

2:00 p.m.–2:10 p.m. Questions and Answers

Ariane Soldatos, MD, Bethesda, MD

2:10 p.m.–2:55 p.m. Diagnosis, Management, and Neurocognitive Outcomes of Crypotcoccal Meningitis
David R. Boulware, MD, MPH, Minneapolis, MN

2:55 p.m.–3:05 p.m. Questions and Answers

David R. Boulware, MD, MPH, Minneapolis, MN

3:05 p.m.–3:20 p.m. Break

3:20 p.m.–4:05 p.m. Next-generation Diagnostics for Encephalitis

Joseph DeRisi, PhD, San Francisco, CA

4:05 p.m.–4:15 p.m. Questions and Answers

Joseph DeRisi, PhD, San Francisco, CA

RECOMMENDED COMPANION COURSE  –  PAGE 14

Infectious, Paraneoplastic, Autoimmune? Diagnosis and Treatment of Rapidly Progressive Encephalopathies

18  2016 Breakthroughs in Neurology